Bio Rad Laboratories Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Bio Rad Laboratories Inc inventory turnover ratio, the Bio Rad Laboratories Inc 's ability to sell and replace its inventory in the third quarter 2026, sequentially increased to 1.64 in the third quarter 2026, yet the ratio remained below the average, as BIO's market remain challenging.Average inventory processing period, for the Bio Rad Laboratories Inc in Sep 30 2026 quarter, has decreased to 223 days, compare to 225 days, in the Jun 30 2026 quarter.

Within Healthcare sector 248 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1160 in the second quarter 2026, to 1691.

BIO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Bio Rad Laboratories Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BIO Inventory Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Inventory Growth	0.09 %	-2.28 %	-2.48 %	-2.54 %	-2.62 %
Y / Y Cost of Sales Growth	6.08 %	-0.26 %	1.08 %	6.73 %	5.46 %
Inventory Turnover Ratio (TTM)	1.64	1.62	1.61	1.6	1.56
BIO's Total Ranking	# 1691	# 1160	# 454	# 428	#
Average inventory processing period	222	225	227	229	234
Seq. Inventory Growth	0.42 %	1.31 %	4.02 %	-5.43 %	-1.95 %
Seq. Cost of Sales Growth	7.4 %	8.23 %	-19.2 %	12.94 %	0.98 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 17
Healthcare Sector	# 249
Overall Market	# 1691

Inventory Turnover Ratio Statistics
High	Average	Low
2.17	1.77	1.45
(Dec 31 2021)		(Jun 30 2012)

BIO Company Profile >> Back to BIO Efficiency Comparisons >> Compare BIO Inventory Turnover Ratio to its Competitors

Financial Statements
Bio Rad Laboratories Inc 's Inventories	$ 784 Millions	Visit BIO's Balance sheet
Bio Rad Laboratories Inc 's Cost of Revenues TTM	$ 1,264 Millions	Visit BIO's Income Statement
What are BIO's Sales?		Visit BIO's Sales by Segment

Other Inventory Turnover Ratios
Bio Rad Laboratories Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BIO's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BIO's Competitors
Inventory Turnover Ratio for BIO's Suppliers
Inventory Turnover Ratio for BIO's Customers

You may also want to know
BIO's Sales Growth Rates	BIO's Pe Price to earnings ratio	BIO's Receivables Turnover Ratio	BIO's Stock Quote
BIO's Net Income Growth Rates	BIO's Ps Price to Sales ratio	BIO's Sales per Employee	BIO's Asset Turnover Ratio
BIO's Net Margin	BIO's Pb Price to Book ratio	BIO's Financial Strength Ratios	BIO's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Sep 30 2026	Inventories at quarter ending Sep 30 2026
Medinotec Inc	4.28	$ 5.143 Millions	$ 1 Millions
3m Company	4.02	$ 15,267.000 Millions	$ 3,801 Millions
Novocure Limited	3.98	$ 166.721 Millions	$ 42 Millions
Incyte Corporation	3.79	$ 439.399 Millions	$ 116 Millions
Baxter International Inc	3.57	$ 8,117.000 Millions	$ 2,277 Millions
Bausch Health Companies Inc	3.54	$ 4,518.000 Millions	$ 1,276 Millions
Exelixis Inc	3.49	$ 93.324 Millions	$ 27 Millions
Abbvie Inc	3.40	$ 17,346.000 Millions	$ 5,108 Millions
Gilead Sciences Inc	3.30	$ 6,219.000 Millions	$ 1,884 Millions
Teva Pharmaceutical Industries Limited	3.16	$ 8,011.000 Millions	$ 2,537 Millions
Msa Safety Inc	3.00	$ 1,063.235 Millions	$ 354 Millions
Mimedx Group Inc	2.98	$ 70.562 Millions	$ 24 Millions
Ligand Pharmaceuticals Incorporated	2.93	$ 34.495 Millions	$ 12 Millions
Neogen Corporation	2.89	$ 464.774 Millions	$ 161 Millions
Zevra Therapeutics Inc	2.82	$ 6.736 Millions	$ 2 Millions
Biomerica Inc	2.65	$ 4.297 Millions	$ 2 Millions
Dexcom Inc	2.65	$ 1,867.500 Millions	$ 705 Millions
Angiodynamics Inc	2.50	$ 142.709 Millions	$ 57 Millions
Pro dex Inc	2.45	$ 53.753 Millions	$ 22 Millions
Illumina Inc	2.36	$ 1,458.000 Millions	$ 618 Millions
Mirum Pharmaceuticals Inc	2.35	$ 59.684 Millions	$ 25 Millions
Aquestive Therapeutics Inc	2.34	$ 16.928 Millions	$ 7 Millions
Resmed Inc	2.33	$ 2,214.675 Millions	$ 952 Millions
Beta Bionics Inc	2.31	$ 53.285 Millions	$ 23 Millions
Merit Medical Systems Inc	2.25	$ 817.001 Millions	$ 363 Millions
Bioventus Inc	2.24	$ 183.856 Millions	$ 82 Millions
Johnson and Johnson	2.17	$ 32,222.000 Millions	$ 14,824 Millions
Standard Biotools Inc	2.16	$ 39.539 Millions	$ 18 Millions
Glaukos Corp	2.13	$ 131.180 Millions	$ 62 Millions
Organon and Co	2.08	$ 2,859.000 Millions	$ 1,371 Millions

Date modified: 2026-11-08T11:22:02+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.